SANA (Sana Biotechnology) 5-Year EBITDA Growth Rate: 14.70% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SANA Sana Biotechnology Inc SANA
32 GF Score
Price $3.85
! 1 Warning Sign
View Full Analysis

What is Sana Biotechnology 5-Year EBITDA Growth Rate?

Sana Biotechnology SANA -1.66% 32 5-Year EBITDA Growth Rate is 14.70% as of Jun. 2026. GuruFocus rates SANA with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

Sana Biotechnology's EBITDA per Share for the three months ended in Jun. 2026 was $-0.21.

During the past 3 years, the average EBITDA Per Share Growth Rate was 17.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 14.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sana Biotechnology was 19.00% per year. The lowest was -8.40% per year. And the median was 11.15% per year.

Sana Biotechnology  (NAS:SANA) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Sana Biotechnology 5-Year EBITDA Growth Rate Related Terms

SANA vs APMD, ODTX, CRVS: 5-Year EBITDA Growth Rate Comparison

For the Biotechnology subindustry, Sana Biotechnology's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sana Biotechnology 5-Year EBITDA Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sana Biotechnology's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sana Biotechnology's 5-Year EBITDA Growth Rate falls into.


SANA
32GF Score
Sana Biotechnology Inc SANA
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sana Biotechnology 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 14.70% mean?
Sana Biotechnology (SANA) has a 5-Year EBITDA Growth Rate of 14.70% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Sana Biotechnology and its competitors.
Is Sana Biotechnology's 5-Year EBITDA Growth Rate too high?
Sana Biotechnology's current 5-Year EBITDA Growth Rate is 14.70%. Overall, Sana Biotechnology has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Sana Biotechnology's 5-Year EBITDA Growth Rate compare to APMD and ODTX?
Sana Biotechnology's 5-Year EBITDA Growth Rate of 14.70% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Biotechnology company?
A good 5-Year EBITDA Growth Rate depends on the Biotechnology industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Sana Biotechnology and its competitors. Sana Biotechnology's current 5-Year EBITDA Growth Rate is 14.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sana Biotechnology stock overvalued right now?
Sana Biotechnology (SANA) has a current 5-Year EBITDA Growth Rate of 14.70%. The current 5-Year EBITDA Growth Rate is 14.70%. Sana Biotechnology's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Sana Biotechnology (SANA), the current 5-Year EBITDA Growth Rate is 14.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sana Biotechnology Business Description

Address 188 East Blaine Street, Suite 350, Seattle, WA, USA, 98102
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
32GF Score

Get the complete analysis for SANA

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.85
Price